Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May-Jun;39(3):e70081.
doi: 10.1111/jvim.70081.

Allele Frequencies and Genotypes for the Ryanodine Receptor 1 Variant Causing Malignant Hyperthermia and Fatal Rhabdomyolysis With Hyperthermia in Horses

Affiliations

Allele Frequencies and Genotypes for the Ryanodine Receptor 1 Variant Causing Malignant Hyperthermia and Fatal Rhabdomyolysis With Hyperthermia in Horses

Monica Aleman et al. J Vet Intern Med. 2025 May-Jun.

Abstract

Background: Fatal anesthesia-induced malignant hyperthermia (MH) and rhabdomyolysis with hyperthermia documented in Quarter Horses (QH) breeds are caused by a missense variant in the ryanodine receptor 1 gene (RYR1: XP_023505430.1.:p.(R2454G), designated as MH). The reported cases to date have all been heterozygous, and the allele frequency is suspected to be low.

Objective: To determine an accurate estimate of MH allele frequency in multiple horse breeds and investigate whether homozygous animals exist in the population.

Animals: In total, 159 227 horses from 16 breeds who were either submitted for clinical evaluation (n = 1500) or genetic testing (n = 157 727) were included.

Methods: Prospective study using banked DNA samples from two diagnostic laboratories determined the presence, zygosity, and estimated population MH allele frequencies.

Results: The MH allele was exclusively detected in 391 QH, 18 Paints (PT), one Appaloosa (AP), and one QH-Clydesdale cross with similar allele frequencies (QH = 0.0013 and PT and AP = 0.0012). In cases submitted for clinical evaluation, death occurred as anesthesia-induced MH or severe acute rhabdomyolysis with hyperthermia (≥ 42°C, 107.6°F) in 51% of N/MH horses. Nineteen of the 20 fatal cases were young males (median: 9 years old, range: 9 months-14 years). No MH homozygotes were detected in either cohort evaluated.

Conclusions and clinical importance: Homozygotes for the MH allele were not identified, and thus might be incompatible with life, but additional testing is needed to confirm. Although the allele frequency was low, being heterozygous poses a risk of death if anesthesia, stress, concurrent illness, breeding, or other stresses occur.

Keywords: equine; genetic testing; hyperthermia; muscle disease.

PubMed Disclaimer

Conflict of interest statement

Rebecca R. Bellone is affiliated with the University of California, Davis, Veterinary Genetics Laboratory, a facility that offers genetic testing for malignant hyperthermia and other veterinary genetics diagnostic testing. The other authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Pedigree of MH affected family. This is not a complete pedigree as only individuals that were genotyped are presented here. Circle = female, square = male, white = N/N, black = N/MH. A = Stallion A, B = Stallion B, * = Breeding of heterozygotes.

Similar articles

References

    1. Denborough M. and Lovell R. R. H., “Anaesthetic Deaths in a Family,” Lancet II (1960): 45. - PubMed
    1. Hopkins P. M., Girard T., Dalay S., et al., “Malignant Hyperthermia 2020: Guideline From the Association of Anaesthetists,” Anaesthesia 76 (2021): 655–664. - PubMed
    1. Mullins M. F., “Malignant Hyperthermia: A Review,” Journal of Perianesthesia Nursing 33 (2018): 582–589. - PubMed
    1. Greenbaum I., Weigl Y., and Pras E., “The Genetic Basis of Malignant Hyperthermia,” Israel Medical Association Journal 9 (2007): 39–41. - PubMed
    1. Denborough M., Hopkinson K. C., O'Brien R. O., and Foster P. S., “Overheating Alone Can Trigger Malignant Hyperthermia in Piglets,” Anaesthesia and Intensive Care 24 (1996): 348–354. - PubMed

Substances

LinkOut - more resources